Also trades as: RNVAW (OTC) · $vol 0M
RNVA OTC
Rennova Health, Inc.
1W: +9900.0%
1M: +9900.0%
3M: +0.0%
YTD: +0.0%
1Y: +9900.0%
3Y: +9900.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$19M
+43.3% ▲
5Y CAGR: +5.1%
Gross Profit
$11M
+77.3% ▲
5Y CAGR: +44.3%
Operating Income
$1M
+196.9% ▲
Net Income
-$8M
-134.7% ▼
EPS (Diluted)
$-0.00
+99.4% ▲
EBITDA
$1M
+567.3% ▲
5Y CAGR: -32.0%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $16M | $7M | $3M | $13M | $19M |
| YoY Growth | +10.0% | -55.0% | -55.2% | +304.4% | +43.3% |
| Cost of Revenue | $16M | $12M | $5M | $7M | $8M |
| Gross Profit | $449K | -$5M | -$2M | $6M | $11M |
| Gross Margin | 2.8% | -63.7% | -64.2% | 48.1% | 59.5% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $16M | $12M | $8M | $7M | $9M |
| Operating Expenses | $16M | $13M | $10M | $8M | $10M |
| Operating Income | -$16M | -$17M | -$13M | -$1M | $1M |
| Operating Margin | -98.1% | -238.8% | -388.4% | -10.8% | 7.3% |
| Interest Expense | $22M | $10M | $3M | $2M | $1M |
| Income Before Tax | -$47M | -$19M | -$5M | -$3M | -$314K |
| Tax Expense | $0 | -$1M | $180K | $313K | $240K |
| Net Income | -$48M | -$18M | $6M | -$3M | -$8M |
| Net Margin | -300.1% | -254.7% | 173.9% | -25.3% | -41.4% |
| EPS (Diluted) | $-3077380701.32 | $-93864830.67 | $-913.37 | $-0.03 | $-0.00 |
| EBITDA | -$24M | -$8M | -$1M | -$310K | $1M |
| Shares Outstanding | 0 | 3 | 548377 | 9.99B | 32.83B |